GLYNIS DEL ROSARIO: Open Payments
NPI 1407353311 · LA QUINTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$48 in 3 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $120 · 2025 $48
Food & beverage: $48
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| CeQur Corporation | 1 | $13 |
Products named: XIFAXAN, MOUNJARO, CeQur Simplicity.
Industry payments across CA — which companies pay providers there.
